Inc. (NASDAQ:INCR) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On April 3, 2019, the Board of Directors of Milestone Scientific Inc. (the “Company”) appointed Neal Goldman as a new independent director of the Company, to serve until the next annual meeting of the stockholders of the Company.
Mr. Goldman is currently president and founder of Goldman Capital Management, Inc., a family office since 1985. Additionally, Mr. Goldman is member of the Board of Directors of ImageWare Systems, Inc., a developer of mobile and cloud-based biometric services, and Chairman of Charles and Colvard, LTD, a specialty jewelry company. Prior to their acquisition, Mr. Goldman served as a member of the Board of Directors of Blyth, Inc. and IPASS corporation.
About Inc. (NASDAQ:INCR)
INC Research Holdings, Inc. is a global contract research organization (CRO). The Company is focused on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services. The Company’s Clinical Development Services segment offers all clinical development services, including full-service global studies, as well as ancillary services, such as clinical monitoring, investigator recruitment, patient recruitment, data management, study reports to assist customers with their drug development process, quality assurance audits and specialized consulting services. The Company’s Phase I Services segment focuses on clinical development services for Phase I trials, which include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds.
